Insmed Inc (NAS:INSM)
$ 69.61 -1.06 (-1.5%) Market Cap: 12.45 Bil Enterprise Value: 12.18 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 67/100

Insmed Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 08:30PM GMT
Release Date Price: $34.92 (+4.02%)
Martin Douglas Auster;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Hey, everybody. This is Marty Auster. I'm the Lead SMID Cap Biotech Analyst here at Crédit Suisse. Welcome again to the 29th Annual Crédit Suisse Healthcare Conference.

I'm joined by Will Lewis, CEO of Insmed. Will, super happy to have you here.

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Glad to be here.

Martin Douglas Auster;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

This is the name I've been covering for, I don't know, 2.5, 3 years now. And really enjoyed the whole process so far. We'd love to kind of get your perspectives and kind of frame around. It feels like you've been on a long hike, and we're finally getting to a place with a great view. What do you...

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

I appreciate that as a metaphor. I would tell you that I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot